Triumvira Immunologics (Series A)
Funding Details
Awarder
Inbox
Date Award
August 27, 2020
Vertical
Immunotherapy
Funding URL
View Funding Page
Funding Amount
$55,000,000
Company Info
Market
Cancer treatment
Location
Austin, Texas, USA
Coinvestors
Bloom Burton & Co, Centre for Commercialization of Cancer Immunotherapy, Leaps by Bayer, Northpond Ventures, Oceanpine Capital, Viva Biotech
Company Description

Triumvira Immunologics is an immunotherapy company that develops novel T cell therapies for cancer.

Links
WebsiteCrunchbaseLinkedIn
Back to HomeBack to Immunotherapy DealsView Funding Announcement